S
Shenzhen Sailu Medical Technology
Biotech & Life Sciences · China · Founded 2020
Explores spatial biology with innovated sequencing technology MoreLess
Salus Biomed is a pioneering company in the field of life sciences, specializing in advanced DNA sequencing and spatial omics research tools. The company serves a diverse range of clients, including academic researchers, clinical laboratories, and biotechnology firms. Operating in the rapidly growing genomics and spatial biology markets, Salus Biomed leverages its proprietary Next-Generation Sequencing (NGS) platform and super-resolution imaging techniques to deliver high-performing DNA sequencers and ultra-high resolution spatial omics tools. These products are designed to support both clinical sequencing applications and fundamental spatial omics studies, offering flexible and rapid data output options ranging from 10 to 240G per run. The business model is centered around the sale of these innovative instruments and associated consumables, as well as providing specialized research services. Revenue is generated through direct sales, service contracts, and collaborative research agreements. Salus Biomed's commitment to innovation and collaboration is evident in its multidisciplinary team of experts in engineering, chemistry, molecular biology, and bioinformatics, all working together to unlock new possibilities in life science.
Keywords: DNA sequencing, spatial omics, genomics, NGS platform, super-resolution imaging, clinical applications, research tools, biotechnology, bioinformatics, life sciences.
Company overview
Shenzhen Sailu Medical Technology company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2020
- Headquarters
- China
- Employees
- 4
- Open positions
- None listed
- Dealroom signal
- 80.9
Valuation & funding
Shenzhen Sailu Medical Technology funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES B✓Equity / VC | Oct 2025 | $6.9M | $289M | Amoy Diagnostic | ↗ |
| SERIES A✓Equity / VC | May 2025 | — | — | Shenzhen Capital Group · Shanghai Fosun Pharmaceutical | ↗ |
| SERIES A✓Equity / VC | Dec 2023 | $28M | $110M | Bangqin Capital · Qianhai FOF · Suzhou Dunhang Investment Management · Shenzhen Capital Group | ↗ |
| EARLY VC✓Equity / VC | Oct 2022 | $14M | $55M | GreatWall Fund · Qilu Investment · Longping Biotechnology | ↗ |
| SEEDEquity / VC | Apr 2022 | $0 | — | Undisclosed | ↗ |
| ANGELEquity / VC | Oct 2021 | ZhenFund | ↗ | ||
| SPINOUT✓Other financing | Jan 2020 | North Carolina State University | — |
Financials
Workforce over time
Available workforce history. Financial fields without reported data are omitted.
| Year | Employees |
|---|---|
| 2026 | 4 |
| 2025 | 4 |
| 2024 | 4 |
| 2023 | 2 |
Growth signals
Shenzhen Sailu Medical Technology website traffic
Latest recorded traffic for Shenzhen Sailu Medical Technology is 430 monthly website visits, up 65.4% over the last three months. Shenzhen Sailu Medical Technology's team grew 0% over the past year.
Comparisons
Shenzhen Sailu Medical Technology compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Shenzhen Sailu Medical Technology's talent
Source: Dealroom Talent Intelligence.
Investors
13 investors on Shenzhen Sailu Medical Technology's cap table
Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.

Global footprint
Where Shenzhen Sailu Medical Technology has talent and traffic
In the news
Latest news about Shenzhen Sailu Medical Technology
Recent press, funding announcements, and product moves mentioning Shenzhen Sailu Medical Technology — open to read from the original sources.
Market sentiment
What the market is saying about Shenzhen Sailu Medical Technology
An AI-synthesized read of the highest-engagement posts about Shenzhen Sailu Medical Technology on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Shenzhen Sailu Medical Technology’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.












